International Assets Investment Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-21,855
Closed -$207K 851
2025
Q1
$207K Sell
21,855
-223
-1% -$22.5K 0.02% 700
2024
Q4
$206K Sell
22,078
-445,967
-95% -$39.3M 0.02% 739
2024
Q3
$25.4K Buy
468,045
+445,449
+1,971% +$35.1M 0.07% 239
2024
Q2
$219K Buy
22,596
+139
+0.6% +$10.2K 0.02% 668
2024
Q1
$187K Buy
22,457
+1,248
+6% +$80.2K 0.02% 693
2023
Q4
$89K Sell
21,209
-69
-0.3% -$3.68K 0.01% 684
2023
Q3
$85.3K Buy
+21,278
New +$1.12M 0.01% 564
2023
Q2
Sell
-22,250
Closed -$131K 635
2023
Q1
$131K Sell
22,250
-325
-1% -$15.3K 0.02% 554
2022
Q4
$138K Buy
22,575
+21,274
+1,635% +$921K 0.01% 675
2022
Q3
$50K Buy
+1,301
New +$52.2K 0.01% 440
2022
Q2
Sell
-20,779
Closed -$54K 473
2022
Q1
$54K Buy
+20,779
New +$901K 0.01% 472
2021
Q2
Sell
-4,425
Closed -$20K 685
2021
Q1
$20K Hold
4,425
﹤0.01% 1295
2020
Q4
$20K Buy
+4,425
New +$159K ﹤0.01% 1158

Other funds holding BSX

International Assets Investment Management's BSX Position: Q2 2025 in Review

International Assets Investment Management sold out of Boston Scientific (BSX) in Q2 2025, closing a stake of 21,855 shares — an estimated $207K sold.

International Assets Investment Management first reported a position in BSX in Q4 2020 and held it in 13 quarters. The position peaked at $219K in Q2 2024. 1,688 funds tracked by Wall St. Rank hold BSX as of Q2 2025.

  • International Assets Investment Management reported no remaining Boston Scientific position as of Q2 2025 after selling out during the quarter.
  • International Assets Investment Management sold 21,855 Boston Scientific shares in Q2 2025, an estimated $207K.
  • International Assets Investment Management first reported a position in Boston Scientific in Q4 2020 and held it in 13 quarters.
  • International Assets Investment Management's Boston Scientific position peaked at $219K in Q2 2024.
  • 1,688 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2025.

Based on International Assets Investment Management's 13F filing for Q2 2025, filed 29 Jul 2025.